missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IFN-gamma R2 Fc Chimera Avi Protein, CF
Click to view available options
:
50 μg
Description
Measured by its binding ability in a functional ELISA. Biotinylated Recombinant Human IFN-gamma R2 Fc Chimera Avi-tag (Catalog # AVI11578) binds Recombinant Human IFN-gamma (Catalog # 285-IF ) in the presence of Recombinant Human IFN-gamma R1/CD119 (Catalog # 673-IR/CF ) with an ED50 of 0.0800-1.20 μg/mL.
Specifications
Specifications
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gene ID (Entrez) | 3460 |
| Molecular Weight (g/mol) | MolecularWeight-observed: 67-74 kDa, under reducing conditions., MolecularWeight-theroretical: 54 kDa |
| Quantity | 50 μg |
| Source | Human embryonic kidney cell, HEK293-derived human IFN-gamma R2 protein Human IFNGR2 (Ala22-Gln247) (N-terminus) Accession # AAA16955.1 GGIEGRMDGG Human IgG1 (Pro100-Lys330) Avi-tag (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Alias | AF-1, AF-1interferon-gamma receptor beta chain precursor10IFNGT1Interferon gamma receptor accessory factor 1, IFGR2, IFN-gamma receptor 2, IFNgammaR2, IFN-gamma-R2, IFN-gR2, IFNGR2, IFNGT1, interferon gamma receptor 2, interferon gamma receptor 2 (interferon gamma transducer 1), interferon gamma receptor accessory factor-1, interferon gamma receptor beta chain, Interferon gamma transducer 1 |
| Conjugate | Biotin |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction